参考文献/References:
[1] Lee CJ,Sears CL,Maruthur N.Gut microbiome and its role in obesity and insulin resistance[J].Ann N Y Acad Sci,2020,1461(1):37-52.DOI:10.1111/nyas.14107.
[2] Human Microbiome Jumpstart Reference Strains Consortium,Nelson KE,Weinstock GM,Highlander SK,et al.A catalog of reference genomes from the human microbiome[J].Science,2010,328(5981):994-999.DOI:10.1126/science.1183605.
[3] Faith JJ,McNulty NP,Rey FE,et al. Predicting a human gut microbiota's response to diet in gnotobiotic mice[J].Science,2011,333(6038):101-104.DOI:10.1126/science.1206025.
[4] Angelakis E,Armougom F,Million M,et al.The relationship between gut microbiota and weight gain in humans[J].Future Microbiol,2012,7(1):91-109.DOI:10.2217/fmb.11.142.
[5] Remely M,Tesar I,Hippe B,et al.Gut microbiota composition correlates with changes in body fat content due to weight loss[J].Benef Microbes,2015,6(4):431-439.DOI:10.3920/BM2014.0104.
[6] Aron-Wisnewsky J,Prifti E,Belda E,et al.Major microbiota dysbiosis in severe obesity:fate after bariatric surgery[J].Gut,2019,68(1):70-82.DOI:10.1136/gutjnl-2018-316103.
[7] Heianza Y,Sun D,Li X,et al.Gut microbiota metabolites,amino acid metabolites and improvements in insulin sensitivity and glucose metabolism:the POUNDS Lost trial[J].Gut,2019,68(2):263-270.DOI:10.1136/gutjnl-2018-316155.
[8] Kootte RS,Levin E,Salojärvi J,et al.Improvement of insulin sensitivity after lean donor feces in metabolic syndrome is driven by baseline intestinal microbiota composition[J].Cell Metab,2017,26(4):611-619.e6.DOI:10.1016/j.cmet.2017.09.008.
[9] Rinott E,Youngster I,Yaskolka Meir A,et al.Effects of diet-modulated autologous fecal microbiota transplantation on weight regain[J].Gastroenterology,2021,160(1):158-173.e10.DOI:10.1053/j.gastro.2020.08.041.
[10] Reijnders D,Goossens GH,Hermes GD,et al.Effects of gut microbiota manipulation by antibiotics on host metabolism in obese humans:a randomized double-blind placebo-controlled trial[J].Cell Metab,2016,24(2):341.DOI:10.1016/j.cmet.2016.07.008.
[11] Zhang H,DiBaise JK,Zuccolo A,et al.Human gut microbiota in obesity and after gastric bypass[J].Proc Natl Acad Sci U S A,2009,106(7):2365-2370.DOI:10.1073/pnas.0812600106.
[12] Furet JP,Kong LC,Tap J,et al.Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss:links with metabolic and low-grade inflammation markers[J].Diabetes,2010,59(12):3049-3057.DOI:10.2337/db10-0253.
[13] Guo Y,Liu CQ,Shan CX,et al.Gut microbiota after Roux-en-Y gastric bypass and sleeve gastrectomy in a diabetic rat model:increased diversity and associations of discriminant genera with metabolic changes[J].Diabetes Metab Res Rev,2017,33(3).DOI:10.1002/dmrr.2857.
[14] Guo Y,Liu CQ,Liu GP,et al.Roux-en-Y gastric bypass decreases endotoxemia and inflammatory stress in association with improvements in gut permeability in obese diabetic rats[J].J Diabetes,2019,11(10):786-793.DOI:10.1111/1753-0407.12906.
[15] Guo Y,Huang ZP,Liu CQ,et al.Modulation of the gut microbiome:a systematic review of the effect of bariatric surgery[J].Eur J Endocrinol,2018,178(1):43-56.DOI:10.1530/EJE-17-0403.
[16] Guo Y,Liu C,Zhao X,et al.Changes in gut microbiota,metabolite SCFAs,and GPR43 expression in obese diabetic mice after sleeve gastrectomy[J].J Appl Microbiol,2022,133(2):555-568.DOI:10.1111/jam.15583.
[17] Tremaroli V,Karlsson F,Werling M,et al.Roux-en-Y gastric bypass and vertical banded gastroplasty induce long-term changes on the human gut microbiome contributing to fat mass regulation[J].Cell Metab,2015,22(2):228-238.DOI:10.1016/j.cmet.2015.07.009.
[18] Gurung M,Li Z,You H,et al.Role of gut microbiota in type 2 diabetes pathophysiology[J].EBioMedicine,2020,51:102590.DOI:10.1016/j.ebiom.2019.11.051.
[19] Meijnikman AS,Gerdes VE,Nieuwdorp M,et al.Evaluating causality of gut microbiota in obesity and diabetes in humans[J].Endocr Rev,2018,39(2):133-153.DOI:10.1210/er.2017-00192.
[20] Sircana A,Framarin L,Leone N,et al.Altered gut microbiota in type 2 diabetes:just a coincidence?[J].Curr Diab Rep,2018,18(10):98.DOI:10.1007/s11892-018-1057-6.
[21] Hansen CH,Krych L,Nielsen DS,et al.Early life treatment with vancomycin propagates Akkermansia muciniphila and reduces diabetes incidence in the NOD mouse[J].Diabetologia,2012,55(8):2285-2294.DOI:10.1007/s00125-012-2564-7.
[22] Fenneman AC,Rampanelli E,Yin YS,et al.Gut microbiota and metabolites in the pathogenesis of endocrine disease[J].Biochem Soc Trans,2020,48(3):915-931.DOI:10.1042/BST20190686.
[23] Baothman OA,Zamzami MA,Taher I,et al.The role of gut microbiota in the development of obesity and diabetes[J].Lipids Health Dis,2016,15:108.DOI:10.1186/s12944-016-0278-4.
[24] Cani PD.Human gut microbiome:hopes,threats and promises[J].Gut,2018,67(9):1716-1725.DOI:10.1136/gutjnl-2018-316723.
[25] de Groot P,Nikolic T,Pellegrini S,et al.Faecal microbiota transplantation halts progression of human new-onset type 1 diabetes in a randomised controlled trial[J].Gut,2021,70(1):92-105.DOI:10.1136/gutjnl-2020-322630.
[26] Neuman V,Cinek O,Funda DP,et al.Human gut microbiota transferred to germ-free NOD mice modulate the progression towards type 1 diabetes regardless of the pace of beta cell function loss in the donor[J].Diabetologia,2019,62(7):1291-1296.DOI:10.1007/s00125-019-4869-2.
[27] Wang H,Lu Y,Yan Y,et al.Promising treatment for type 2 diabetes:fecal microbiota transplantation reverses insulin resistance and impaired islets[J].Front Cell Infect Microbiol,2020,9:455.DOI:10.3389/fcimb.2019.00455.
[28] Ng SC,Xu Z,Mak JWY,et al.Microbiota engraftment after faecal microbiota transplantation in obese subjects with type 2 diabetes:a 24-week,double-blind,randomised controlled trial[J].Gut,2022,71(4):716-723.DOI:10.1136/gutjnl-2020-323617.
[29] Su L,Hong Z,Zhou T,et al.Health improvements of type 2 diabetic patients through diet and diet plus fecal microbiota transplantation[J].Sci Rep,2022,12(1):1152.DOI:10.1038/s41598-022-05127-9.
[30] Fenneman AC,Bruinstroop E,Nieuwdorp M,et al.A comprehensive review of thyroid hormone metabolism in the gut and its clinical implications[J].Thyroid,2022,DOI:10.1089/thy.2022.0491.
[31] Gong B,Wang C,Meng F,et al.Association between gut microbiota and autoimmune thyroid disease:a systematic review and Meta-Analysis[J].Front Endocrinol(Lausanne),2021,12:774362.DOI:10.3389/fendo.2021.774362.
[32] Jiang W,Yu X,Kosik RO,et al.Gut microbiota may play a significant role in the pathogenesis of Graves' disease[J].Thyroid,2021,31(5):810-820.DOI:10.1089/thy.2020.0193.
[33] Su X,Zhao Y,Li Y,et al.Gut dysbiosis is associated with primary hypothyroidism with interaction on gut-thyroid axis[J].Clin Sci(Lond),2020,134(12):1521-1535.DOI:10.1042/CS20200475.
[34] Su X,Yin X,Liu Y,et al.Gut dysbiosis contributes to the imbalance of Treg and Th17 cells in Graves' disease patients by propionic acid[J].J Clin Endocrinol Metab,2020,105(11).DOI:10.1210/clinem/dgaa511.
[35] Moshkelgosha S,Verhasselt HL,Masetti G,et al.Modulating gut microbiota in a mouse model of Graves' orbitopathy and its impact on induced disease[J].Microbiome,2021,9(1):45.DOI:10.1186/s40168-020-00952-4.
[36] Qi X,Yun C,Pang Y,et al.The impact of the gut microbiota on the reproductive and metabolic endocrine system[J].Gut Microbes,2021,13(1):1-21.DOI:10.1080/19490976.2021.1894070.
[37] Kelley ST,Skarra DV,Rivera AJ,et al.The gut microbiome is altered in a Letrozole-Induced mouse model of polycystic ovary syndrome[J].PLoS One,2016,11(1):e0146509.DOI:10.1371/journal.pone.0146509.
[38] Liu R,Zhang C,Shi Y,et al.Dysbiosis of gut microbiota associated with clinical parameters in polycystic ovary syndrome[J].Front Microbiol,2017,8:324.DOI:10.3389/fmicb.2017.00324.
[39] Guo Y,Qi Y,Yang X,et al.Association between polycystic ovary syndrome and gut microbiota[J].PLoS One,2016,11(4):e0153196.DOI:10.1371/journal.pone.0153196.
[40] Ahmadi S,Jamilian M,Karamali M,et al.Probiotic supplementation and the effects on weight loss,glycaemia and lipid profiles in women with polycystic ovary syndrome:a randomized,double-blind,placebo-controlled trial[J].Hum Fertil(Camb),2017,20(4):254-261.DOI:10.1080/14647273.2017.1283446.
[41] Shoaei T,Heidari-Beni M,Tehrani HG,et al.Effects of probiotic supplementation on pancreatic β-cell function and C-reactive protein in women with polycystic ovary syndrome:a randomized double-blind placebo-controlled clinical trial[J].Int J Prev Med,2015,6:27.DOI:10.4103/2008-7802.153866.
[42] Jamilian M,Mansury S,Bahmani F,et al.The effects of probiotic and selenium co-supplementation on parameters of mental health,hormonal profiles,and biomarkers of inflammation and oxidative stress in women with polycystic ovary syndrome[J].J Ovarian Res,2018,11(1):80.DOI:10.1186/s13048-018-0457-1.